ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 113 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,178 | +70.2% | 133,396 | +47.2% | 0.12% | +36.0% |
Q4 2022 | $692 | -99.7% | 90,603 | +215.7% | 0.09% | +218.5% |
Q3 2022 | $204,000 | +4.1% | 28,702 | +18.4% | 0.03% | -6.9% |
Q2 2022 | $196,000 | -6.7% | 24,245 | +223.9% | 0.03% | +11.5% |
Q4 2021 | $210,000 | -27.6% | 7,485 | +24.8% | 0.03% | -18.8% |
Q2 2019 | $290,000 | – | 6,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Matrix Capital Management Company, LP | 17,332,191 | $535,565,000 | 13.21% |
TIGER MANAGEMENT L.L.C. | 1,115,411 | $34,466,000 | 13.06% |
VIKING GLOBAL INVESTORS LP | 38,406,607 | $1,186,764,000 | 6.18% |
Senator Investment Group LP | 5,113,085 | $146,145,000 | 3.67% |
Casdin Capital, LLC | 463,125 | $14,310,562,000 | 1.48% |
Graticule Asia Macro Advisors LLC | 356,326 | $11,010,000 | 0.86% |
Ratan Capital Management LP | 41,272 | $1,275,000 | 0.67% |
Rock Springs Capital Management LP | 545,000 | $16,841,000 | 0.67% |
MYDA Advisors LLC | 34,000 | $1,051,000 | 0.48% |
Aristotle Atlantic Partners, LLC | 50,459 | $1,559,000 | 0.45% |